Matinas BioPharma Holdings, Inc. (MTNB)
MTNB has a market cap or net worth of $54.23 million. The enterprise value is $39.67 million.
The last earnings date was Wednesday, November 8, 2023, after market close.
|Earnings Date||Nov 8, 2023|
MTNB has 217.27 million shares outstanding. The number of shares has increased by 0.18% in one year.
|Shares Change (YoY)||+0.18%|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||2.92%|
|Owned by Institutions (%)||12.17%|
|EV / Earnings||n/a|
|EV / Sales||9.26|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 6.19, with a Debt / Equity ratio of 0.16.
|Debt / Equity||0.16|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -70.70% and return on invested capital (ROIC) is -86.97%.
|Return on Equity (ROE)||-70.70%|
|Return on Assets (ROA)||-57.90%|
|Return on Capital (ROIC)||-86.97%|
|Revenue Per Employee||$126,000|
|Profits Per Employee||-$625,369|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -56.97% in the last 52 weeks. The beta is 1.85, so MTNB's price volatility has been higher than the market average.
|52-Week Price Change||-56.97%|
|50-Day Moving Average||0.22|
|200-Day Moving Average||0.34|
|Relative Strength Index (RSI)||57.11|
|Average Volume (30 Days)||9,317,731|
Short Selling Information
The latest short interest is 4.45 million, so 2.05% of the outstanding shares have been sold short.
|Short Previous Month||6.02M|
|Short % of Shares Out||2.05%|
|Short % of Float||2.12%|
|Short Ratio (days to cover)||1.00|
In the last 12 months, MTNB had revenue of $4.28 million and -$21.26 million in losses. Loss per share was -$0.11.
|Loss Per Share||-$0.11|
The company has $18.27 million in cash and $3.71 million in debt, giving a net cash position of $14.56 million or $0.07 per share.
|Cash & Cash Equivalents||18.27M|
|Net Cash Per Share||$0.07|
|Equity / Book Value||23.15M|
|Book Value Per Share||0.11|
In the last 12 months, operating cash flow was -$15.00 million and capital expenditures -$259,601, giving a free cash flow of -$15.26 million.
|Operating Cash Flow||-15.00M|
|Free Cash Flow||-15.26M|
|FCF Per Share||-$0.07|
Gross margin is 100.00%, with operating and profit margins of -545.25% and -496.32%.
Dividends & Yields
MTNB does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for MTNB is $3.00, which is 1,101.92% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||1,101.92%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||69.20%|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|
MTNB has an Altman Z-Score of -4.64 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.